OTCMKTS:ARTH - Arch Therapeutics Price Target & Analyst Ratings

$0.3299
0.00 (0.00 %)
(As of 07/21/2019 04:00 PM ET)
Today's Range
$0.2901
Now: $0.3299
$0.3299
50-Day Range
$0.2740
MA: $0.31
$0.37
52-Week Range
$0.26
Now: $0.3299
$0.62
Volume29,200 shs
Average Volume200,998 shs
Market Capitalization$56.93 million
P/E RatioN/A
Dividend YieldN/A
Beta0.12

Analyst Ratings

Arch Therapeutics (OTCMKTS:ARTH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Arch Therapeutics in the last 12 months. Their average twelve-month price target is $1.8750, suggesting that the stock has a possible upside of 468.35%. The high price target for ARTH is $2.50 and the low price target for ARTH is $1.25. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.253.253.253.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.8750$1.8750$2.50$3.00
Price Target Upside: 468.35% upside562.54% upside541.03% upside672.80% upside

Arch Therapeutics (OTCMKTS:ARTH) Consensus Price Target History

Arch Therapeutics (OTCMKTS:ARTH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/15/2019LADENBURG THALM/SH SHReiterated RatingBuy$1.25View Rating Details
3/18/2019HC WainwrightReiterated RatingBuy$2.50View Rating Details
2/5/2019Roth CapitalReiterated RatingBuyView Rating Details
2/1/2019Ifs SecuritiesUpgradeOutperform ➝ Strong-BuyView Rating Details
(Data available from 7/21/2017 forward)
This page was last updated on 7/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel